MedPath

Technetium Tc-99m pyrophosphate

Generic Name
Technetium Tc-99m pyrophosphate
Drug Type
Small Molecule
Chemical Formula
O7P2Tc
CAS Number
52997-54-3
Unique Ingredient Identifier
5L76I61H2B

Overview

A radionuclide imaging agent used primarily in scintigraphy or tomography of the heart to evaluate the extent of the necrotic myocardial process. It has also been used in noninvasive tests for the distribution of organ involvement in different types of amyloidosis and for the evaluation of muscle necrosis in the extremities.

Background

A radionuclide imaging agent used primarily in scintigraphy or tomography of the heart to evaluate the extent of the necrotic myocardial process. It has also been used in noninvasive tests for the distribution of organ involvement in different types of amyloidosis and for the evaluation of muscle necrosis in the extremities.

Indication

For use as a skeletal imaging agent used to demonstrate areas of altered osteogenesis, and a cardiac imaging agent used as an adjunct in the diagnosis of acute myocardial infarction . May also be used to image gated blood pools and detect gastrointetinal bleeding.

Associated Conditions

  • Gastrointestinal Hemorrhage
  • Altered osteogenesis

Clinical Trials

FDA Approved Products

Kit for the Preparation of Technetium Tc99m Pyrophosphate
Manufacturer:Sun Pharmaceutical Industries, Inc.
Route:INTRAVENOUS
Strength:12 mg in 10 mL
Approved: 2019/08/20
NDC:45567-0060

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath